A single amino acid substitution in the putative redox partner-binding site of P450c17 as cause of isolated 17,20-lyase deficiency.
The molecular basis of isolated 17,20-lyase deficiency was clarified in a newborn male patient from Israel with micropenis, undescended testes, and hormonal pattern consistent with isolated 17,20-lyase deficiency. Analysis of the CYP17 gene revealed the presence of a compound heterozygosity. One allele carries a single base pair deletion (T at position 198 in exon 1) leading to a frame shift with the introduction of a premature stop codon, TGA, at residue 74 in place of Val. The other allele bears a missense mutation due to a single base change, T to G, which substitutes Phe417 with Cys. The proof of heterozygosity was possible via amplification and direct sequencing of genomic DNA fragments from the parents and the healthy brother of the index case. We could demonstrate that the mother is the carrier of the nonsense mutation and the father of the missense mutation. The brother carries two normal alleles for the CYP17 gene. The nonsense mutation gives no functional product. The missense mutation causes the synthesis of a protein that retains 17 alpha-hydroxylase activity but virtually no 17,20-lyase activity. Experiments based on the use of an electron donor independent from enzyme binding (iodosobenzene) demonstrated that the addition of electrons restores, at least in part, in vitro 17,20-lyase activity, with no significant influence on the 17 alpha-hydroxylase activity. This suggests that the electron transfer system plays a major role in the differential regulation of the two P450c17 activities. This is the first case of mutated CYP17 in which the in vitro model corresponds to the in vivo situation.
Biason-Lauber
A
A
Pediatric Endocrine Unit, Soroka Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Leiberman
E
E
Zachmann
M
M
D000312:Adrenal Hyperplasia, Congenital; D000483:Alleles; D000818:Animals; D001665:Binding Sites; D015139:Blotting, Southern; D019556:COS Cells; D016368:Frameshift Mutation; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009154:Mutation; D010084:Oxidation-Reduction; D010375:Pedigree; D010649:Phenylalanine; D017422:Sequence Analysis, DNA; D013254:Steroid 17-alpha-Hydroxylase / Q000737:chemistry* / Q000235:genetics; D014162:Transfection
D010649:Phenylalanine; D013254:Steroid 17-alpha-Hydroxylase